本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

百德医疗

1.57
-0.0100-0.63%
盘后1.570.00000.00%19:52 EDT
成交量:23.46万
成交额:36.71万
市值:5,811.50万
市盈率:3.22
高:1.64
开:1.64
低:1.52
收:1.58
52周最高:12.50
52周最低:1.05
股本:3,701.59万
流通股本:1,096.85万
量比:0.17
换手率:2.14%
股息:- -
股息率:- -
每股收益(TTM):0.4873
每股收益(LYR):0.4873
净资产收益率:33.39%
总资产收益率:14.22%
市净率:1.47
市盈率(LYR):3.22

数据加载中...

2025/08/08

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/05/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/17

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/09/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/09/04

SEC问询函

Form CORRESP - Correspondence
2024/08/27

SEC问询函

Form CORRESP - Correspondence
2024/08/10

SEC问询函

Form CORRESP - Correspondence
2024/07/20

SEC问询函

Form CORRESP - Correspondence
2024/06/21

SEC问询函

Form CORRESP - Correspondence
2024/03/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/03/16

SEC问询函

Form CORRESP - Correspondence
2024/01/27

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/01/20

SEC问询函

Form CORRESP - Correspondence
2023/12/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/29

SEC问询函

Form CORRESP - Correspondence
2023/11/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations